Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Pneumovax 23 Vaccine

Prescription Icon
Prescription Required

Marketer

MSD Pharmaceuticals Pvt Ltd

Salt Composition

Pneumococcal Polysaccharide Vaccine (25mcg)

Overview Pneumovax 23 Vaccine

The pneumococcal polysaccharide vaccine, Pneumovax 23, protects against illnesses stemming from pneumococcal bacteria, including pneumonia, meningitis, otitis media, and bacteremia. Administered intramuscularly in the upper arm by a healthcare professional, self-injection is strictly prohibited. A single dose suffices for most individuals; however, a booster shot may be recommended five years post-initial vaccination. Mild side effects, such as fever and localized injection site reactions (pain, swelling, redness), are possible. Persistent or worsening symptoms warrant medical attention; your physician can offer strategies for symptom management. Prior to vaccination, disclose any pre-existing cardiac, hepatic, or renal conditions, and provide a complete medication list to your doctor. Expectant and nursing mothers should consult their physician before vaccination.

Uses of Pneumovax 23 Vaccine

Protecting against pneumonia, meningitis, bloodstream infections, and otitis media.

Major Benefits of Pneumovax 23 Vaccine:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Pneumovax 23 Vaccine:

  • Injection site redness
  • Fever

How to use Pneumovax 23 Vaccine:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Pneumovax 23 Vaccine works:

The Pneumovax 23 vaccine prompts the body to build immunity through a safe, non-disease-causing response. This process mimics infection, triggering antibody production—protective proteins that safeguard against subsequent pneumococcal illnesses.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Pneumovax 23 vaccination lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Pneumovax 23 vaccination in pregnant women is currently unavailable. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Pneumovax 23 Vaccine administration while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingSAFE

The Pneumovax 23 vaccine typically has no impact on driving capabilities.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Pneumovax 23 vaccination in individuals with renal impairment is scarce. Seek medical advice from your physician.

LiverLiverCONSULT YOUR DOCTOR

Data on Pneumovax 23 Vaccine use in individuals with hepatic impairment is scarce. Seek medical advice from your physician.

What if you forget to take Pneumovax 23 Vaccine :

Should you forget a Pneumovax 23 vaccination, seek your physician's advice.

Facts to Know About Pneumovax 23 Vaccine

LabelValue
Chemical Category Immunizations
Developing Habits No.
Type of Therapy Immunizations

FAQs on Pneumovax 23 Vaccine

Pneumovax 23 is not a live virus vaccine. It's made from purified capsular polysaccharides of 23 pneumococcal bacteria types. While not effective against all pneumococcal infections, it offers protection against most.
Pneumovax 23 uses long chains of polysaccharide (sugar) molecules, mirroring the surface capsule of the bacteria. These polysaccharides act as antigens, stimulating antibody production to combat infection.
Pneumovax 23 is a safe vaccine, rigorously tested and continually monitored. Minor side effects, such as injection site pain, swelling, or mild fever, may occur but usually resolve within days. Seek medical advice if symptoms persist.
One dose of PPSV is needed for you or your child. A second dose isn't typically recommended for healthy individuals and is usually given at least 3 years after the first. However, a second dose may be considered 3-5 years after the initial dose for those at higher risk of serious pneumococcal infections (e.g., individuals lacking a spleen or with a malfunctioning spleen). Administering a second dose within 3 years is discouraged due to increased side effect risks.
Ideally, receive the Pneumovax 23 vaccine two weeks before splenectomy, chemotherapy, or other immunosuppressive treatments. Avoid vaccination during chemotherapy or radiation. Immune response may be reduced even after these therapies conclude; therefore, wait at least three months post-treatment for vaccination. For extensive or intensive therapy, a longer delay might be necessary.
Pneumovax 23 and influenza vaccines, or other vaccines, may be administered concurrently, using separate syringes and injection sites. Simultaneous vaccination typically provides protection against both infections.
Vaccination is generally safe for minor illnesses like colds. However, if you have a fever or a serious ongoing health condition, postpone vaccination until you've recovered. Always consult your doctor before getting vaccinated.
Pneumovax 23 Vaccine
1,982
MRP 2,300
13% off